INTRODUCTION:
Lymphoscintigraphy is the gold-standard test for diagnosing lymphedema, and is 96% sensitive for detecting the disease. The major abnormal lymphoscintigraphic findings on the test include delayed transit time to the inguinal or axillary lymph nodes (>1 hour) and dermal backflow. A universal protocol for the test does not exist, our protocol obtains images at 1, 2, and 4 hour intervals to confirm diagnosis of the disease and to achieve a measure of the severity of lymphatic dysfunction (e.g., a patient with a transit time of 4 hours to regional lymph nodes would have worse dysfunction compared to a patient with a transit time of 2 hours). The purpose of this project was to determine if lymphoscintigraphy results correlate with clinical presentation.
METHODS: Patients treated in our Lymphedema
Program between 2009 and 2017 were reviewed. Diagnosis of lymphedema was determined by history, physical examination, and lymphoscintigraphy. Severity was defined by increased volume of the limb: mild (<20%), moderate (20-40%), severe (>40%). Candidate variables included location (arm, leg), age, duration of symptoms, infection history, and lymphedema type (primary, secondary). An association between lymphedema severity and lymphoscintigraphy findings was determined using the Pearson chi-square test and multivariate logistic regression.
RESULTS:
One hundred thirty-four patients with 181 affected extremities (24 upper, 157 lower) were included. Clinical severity was: 54% mild, 30% moderate, and 16% severe. Delayed tracer transit to the regional nodes was: 45 minutes (34%), 2 hours (18%), and ≥ 4 hours (48%). Thirty-six percent of extremities demonstrated dermal backflow. Abnormal transit time or dermal backflow was identified in 97% of extremities by 45 minutes and in 3% of limbs by 2 hours. Transit time and dermal backflow were not predictive of clinical severity when adjusting for candidate variables (p > 0.1).
CONCLUSION:
Clinical severity of lymphedema is not associated with lymphoscintigraphy findings. A lymphoscintigram should be interpreted as normal or abnormal, and does not need to exceed 2 hours. 
Revolutionizing Remote Monitoring of

INTRODUCTION:
Newer generation of free flap monitoring device using tissue oximetry offers webbased capability for transmission of recordings to the smart phone. However, remote monitoring capability does not currently exist for the Perimed laser Doppler (Perimed AB, Järfälla, Sweden) when used without connection to a computer. Using an existing tablet and a free app (application), the smart device can be converted into a Wi-Fi camera, which can be placed adjacent to the laser Doppler monitor to allow instant, real-time monitoring remotely. Multiple apps are currently available which can convert a smart phone or tablet (e.g. iPad) into a remote camera, which can then be linked to the provider's smartphone over the internet.
METHODS:
We present our preliminary experience with this smart device app to a well-established modality, laser Doppler flowmetry, 1,2 for monitoring free flaps. We employed the AtHome app from the app store which converted a used iPad into a camera and multiple smart phones into independent viewers. No patient identifier was transmitted with this remote monitoring set-up.
RESULTS:
We monitored 9 head and neck free flaps, each for 4-6 days remotely with near 100%
